Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M C Jaudon

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Prognostic relevance of a scoring system based on clinical and biological parameters in early chronic lymphocytic leukemiaS Leotard, C Chastang, P Travade, et al.
Annales De Biologie Clinique|January 1, 1990
[Glycosylated plasma proteins in chronic renal failure]M Bordas-Fondrede, E Sauser, C Jardel, et al.
Presse Medicale (Paris, France : 1983)|November 4, 1989
[Value of plasma fructosamine in non-diabetic and diabetic chronic renal failure]J Delattre, J Rottembourg, Y Thuillier-Juteau, et al.
Cardiovascular Drugs and Therapy|November 1, 1996
Antioxidant status of hypercholesterolemic patients treated with LDL apheresisS Lepage, D Bonnefont-Rousselot, E Bruckert, et al.
Revue Neurologique|March 1, 1977
[Neuropathologic and toxicologic study of 12 cases of bismuth encephalopathy]R Escourolle, R Bourdon, A Galli, et al.
Presse Medicale (Paris, France : 1983)|November 14, 1992
[Oxidative stress in 29 HIV seropositive patients. Two-year results of a double-blind trial of diethyldithiocarbamate versus placebo]A Coutellier, D Bonnefont-Rousselot, J Delattre, et al.
La Nouvelle Presse Medicale|June 10, 1978
[Prolonged and reversible encephalopathy in a chronic haemodialysis patient. Probable responsibility of aluminium salts (author's transl)]A Buge, M Poisson, S Masson, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|September 15, 1995
Preferential depletion of selenoprotein P in hypercholesterolaemic patients treated by LDL-apheresisM Persson-Moschos, D Bonnefont-Rousselot, U Assogba, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 1, 1997
Antioxidant status of elderly chronic renal patients treated by continuous ambulatory peritoneal dialysisD Bonnefont-Rousselot, M C Jaudon, B Issad, et al.
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association|January 1, 1983
Substitution of aluminium hydroxide by high doses of calcium carbonate in patients on chronic haemodialysis: disappearance of hyperaluminaemia and equal control of hyperparathyroidismP Moriniere, A Roussel, Y Tahiri, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Prognostic relevance of a scoring system based on clinical and biological parameters in early chronic lymphocytic leukemiaS Leotard, C Chastang, P Travade, et al.
Annales De Biologie Clinique|January 1, 1990
[Glycosylated plasma proteins in chronic renal failure]M Bordas-Fondrede, E Sauser, C Jardel, et al.
Presse Medicale (Paris, France : 1983)|November 4, 1989
[Value of plasma fructosamine in non-diabetic and diabetic chronic renal failure]J Delattre, J Rottembourg, Y Thuillier-Juteau, et al.
Cardiovascular Drugs and Therapy|November 1, 1996
Antioxidant status of hypercholesterolemic patients treated with LDL apheresisS Lepage, D Bonnefont-Rousselot, E Bruckert, et al.
Revue Neurologique|March 1, 1977
[Neuropathologic and toxicologic study of 12 cases of bismuth encephalopathy]R Escourolle, R Bourdon, A Galli, et al.
Presse Medicale (Paris, France : 1983)|November 14, 1992
[Oxidative stress in 29 HIV seropositive patients. Two-year results of a double-blind trial of diethyldithiocarbamate versus placebo]A Coutellier, D Bonnefont-Rousselot, J Delattre, et al.
La Nouvelle Presse Medicale|June 10, 1978
[Prolonged and reversible encephalopathy in a chronic haemodialysis patient. Probable responsibility of aluminium salts (author's transl)]A Buge, M Poisson, S Masson, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|September 15, 1995
Preferential depletion of selenoprotein P in hypercholesterolaemic patients treated by LDL-apheresisM Persson-Moschos, D Bonnefont-Rousselot, U Assogba, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 1, 1997
Antioxidant status of elderly chronic renal patients treated by continuous ambulatory peritoneal dialysisD Bonnefont-Rousselot, M C Jaudon, B Issad, et al.
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association|January 1, 1983
Substitution of aluminium hydroxide by high doses of calcium carbonate in patients on chronic haemodialysis: disappearance of hyperaluminaemia and equal control of hyperparathyroidismP Moriniere, A Roussel, Y Tahiri, et al.
Pageof 6